Literature DB >> 17460063

CNS progenitor cells promote a permissive environment for neurite outgrowth via a matrix metalloproteinase-2-dependent mechanism.

Yiqin Zhang1, Henry J Klassen, Budd A Tucker, Maria-Thereza R Perez, Michael J Young.   

Abstract

Transplantation of progenitor cells to the CNS has shown promise in neuronal and glial replacement and as a means of rescuing host neurons from apoptosis. Here we examined the effect of progenitor grafts on neurite extension in the degenerating retina of rd1 (retinal degeneration 1) mice. Transplantation of retinal progenitor cells induced increased matrix metalloproteinase-2 (MMP2) secretion, partly from activated glial cells, which was then activated by neuronally expressed MMP14. Active MMP2 resulted in proteolysis of the neurite outgrowth inhibitors CD44 and neurocan in the degenerative retina, allowing significantly increased neurite outgrowth across the border between abutting nondystrophic and rd1 retinas. Progenitor-induced enhancement of outgrowth was abrogated by an MMP inhibitor or by coculture with retinal explants from MMP2-/- mice. This study provides the first identification of an MMP2-dependent mechanism by which exogenous progenitor cells alter the host environment to promote neural regeneration. This suggests a novel therapeutic role for progenitor cells in the treatment of CNS degenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17460063      PMCID: PMC6673008          DOI: 10.1523/JNEUROSCI.0200-07.2007

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  36 in total

Review 1.  Lectican proteoglycans, their cleaving metalloproteinases, and plasticity in the central nervous system extracellular microenvironment.

Authors:  M D Howell; P E Gottschall
Journal:  Neuroscience       Date:  2012-05-22       Impact factor: 3.590

Review 2.  Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?

Authors:  Santiago Rivera; Michel Khrestchatisky; Leszek Kaczmarek; Gary A Rosenberg; Diane M Jaworski
Journal:  J Neurosci       Date:  2010-11-17       Impact factor: 6.167

Review 3.  Regenerative therapies for central nervous system diseases: a biomaterials approach.

Authors:  Roger Y Tam; Tobias Fuehrmann; Nikolaos Mitrousis; Molly S Shoichet
Journal:  Neuropsychopharmacology       Date:  2013-09-04       Impact factor: 7.853

Review 4.  Cell therapy for multiple sclerosis.

Authors:  Tamir Ben-Hur
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

Review 5.  Matrix Metalloproteinases During Axonal Regeneration, a Multifactorial Role from Start to Finish.

Authors:  Lien Andries; Inge Van Hove; Lieve Moons; Lies De Groef
Journal:  Mol Neurobiol       Date:  2016-02-29       Impact factor: 5.590

6.  Id4 suppresses MMP2-mediated invasion of glioblastoma-derived cells by direct inactivation of Twist1 function.

Authors:  G J Rahme; M A Israel
Journal:  Oncogene       Date:  2014-01-13       Impact factor: 9.867

7.  Scaffolds and stem cells: delivery of cell transplants for retinal degenerations.

Authors:  Karl E Kador; Jeffrey L Goldberg
Journal:  Expert Rev Ophthalmol       Date:  2012-10-01

8.  Inhibition of MMP-2 but not MMP-9 influences inner ear spiral ganglion neurons in vitro.

Authors:  Michael Sung; Eric Wei; Eduardo Chavez; Neha Jain; Soledad Levano; Laura Binkert; Alessia Ramseier; Cristian Setz; Daniel Bodmer; Allen F Ryan; Yves Brand
Journal:  Cell Mol Neurobiol       Date:  2014-06-17       Impact factor: 5.046

9.  Elevated MMP Expression in the MRL Mouse Retina Creates a Permissive Environment for Retinal Regeneration.

Authors:  Budd Tucker; Henry Klassen; Liu Yang; Dong Feng Chen; Michael J Young
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04       Impact factor: 4.799

10.  Laser injury promotes migration and integration of retinal progenitor cells into host retina.

Authors:  Caihui Jiang; Henry Klassen; Xinmei Zhang; Michael Young
Journal:  Mol Vis       Date:  2010-06-04       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.